NASDAQ Companies

FDA feedback allows for forward program developmentCompany reiterates that its favorable safety profile and its advanced manufacturing and analytics capabilities […]

LAFAYETTE, La., July 22, 2020 (GLOBE NEWSWIRE) — LHC Group, Inc. (NASDAQ: LHCG) today announced details for the release of […]

WOBURN, Mass., July 22, 2020 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies […]

Phase 2/3 study process initiated in Brazil and Mexico The global Phase 2/3 study with opaganib in patients with severe COVID-19 […]

Total Purchase Consideration of $675 MillionCommences Voluntary Chapter 11 Proceedings for U.S. Entities to Implement Salewith New Liquidity of $80 […]

DEVON, Pa., July 22, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]

IRVINE, Calif., July 22, 2020 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) today announced that it has filed a new […]

Second Quarter Financial Highlights*Record revenues of $184.8 million, up 47%Record operating income of $104.1 million, up 71%Record operating margin of […]

STAMFORD, Conn., July 22, 2020 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing […]

Second quarter diluted earnings per share of $0.65, an increase of 18.2% compared to same period in 2019;Second quarter net […]